Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00111150 · ClinicalTrials.gov registry record · Phase 2
Botswana Tenofovir Oral HIV Prophylaxis Trial
A Phase 2 study, sponsored by Centers for Disease Control and Prevention.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1,200
- Enrollment target
NCT00111150 is a Phase 2 study that was terminated before completion, run by Centers for Disease Control and Prevention. The registered enrollment target is 1,200 participants.
The verdict
NCT00111150, a Phase 2 study, was terminated before completion, sponsored by Centers for Disease Control and Prevention.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1,200 participants
- Enrollment target
Study Summary
This study will test whether taking a pill of tenofovir (an antiretroviral medicine) is safe for sexually-active young adults in Botswana without HIV infection and whether it will reduce their risk of getting an HIV infection.
Interventions
- DRUG Tenofovir Disoproxil Fumarate 300 mg daily
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2005-09 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00111150
The ClinicalTrials.gov registry entry for NCT00111150 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tenofovir Disoproxil Fumarate 300 mg daily is the first listed.
NCT00111150 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00111150 about?
NCT00111150 is a clinical study titled "Botswana Tenofovir Oral HIV Prophylaxis Trial". This study will test whether taking a pill of tenofovir (an antiretroviral medicine) is safe for sexually-active young adults in Botswana without HIV infection and whether it will reduce their risk of getting an HIV infection.
What is the current status of trial NCT00111150?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1,200 participants. The study started on 2005-09. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00111150?
The interventions under investigation include: Tenofovir Disoproxil Fumarate 300 mg daily (DRUG).
Who is sponsoring clinical trial NCT00111150?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.